Acute Myeloid Leukemia Coverage From Every Angle
Advertisement
Advertisement

Abhishek Maiti, MBBS, on Comparing Treatment Regimens for Older Patients With AML

Posted: Monday, July 13, 2020

Abhishek Maiti, MBBS, of The University of Texas MD Anderson Cancer Center, discusses results of his study on a 10-day treatment with decitabine and venetoclax, the tolerability of the investigational regimen vs intensive chemotherapy, and the relative toxicity.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.